Correlation Between Pmv Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Pmv Pharmaceuticals and Virax Biolabs
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pmv and Virax is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.28 times more return on investment than Virax Biolabs. However, Pmv Pharmaceuticals is 3.58 times less risky than Virax Biolabs. It trades about -0.13 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.1 per unit of risk. If you would invest 153.00 in Pmv Pharmaceuticals on November 3, 2024 and sell it today you would lose (11.00) from holding Pmv Pharmaceuticals or give up 7.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| Virax Biolabs Group |
Pmv Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Pmv Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen | Pmv Pharmaceuticals vs. Anebulo Pharmaceuticals |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |